Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
Aeglea BioTherapeutics reports 2022 executive compensation
By ExecPay News
Published: October 26, 2023
Aeglea BioTherapeutics reported fiscal year 2022 executive compensation information on October 26, 2023.
In 2022, five executives at Aeglea BioTherapeutics received on average a compensation package of $1.4M, a 19% decrease compared to previous year.
Average pay of disclosed executives at Aeglea BioTherapeutics
Anthony G. Quinn, Chief Executive Officer, received $2.4M in total, which decreased by 9% compared to 2021.
Jeffrey M. Goldberg, Chief Executive Officer, received a compensation package of $1.8M. 97% of the compensation package, or $1.8M, was in option awards.
Leslie Sloan, Chief Operating Officer, earned $1.1M in 2022, a 25% decrease compared to previous year.
Jonathan Alspaugh, Chief Financial Officer, received $1M in 2022.
Jim Kastenmayer, Chief Executive Officer, earned $866K in 2022.
Related executives
Jeffrey Goldberg
Aeglea BioTherapeutics
Chief Executive Officer
Jim Kastenmayer
Aeglea BioTherapeutics
Chief Executive Officer
Anthony Quinn
Aeglea BioTherapeutics
Chief Executive Officer
Jonathan Alspaugh
Aeglea BioTherapeutics
Chief Financial Officer
Leslie Sloan
Aeglea BioTherapeutics
Chief Operating Officer
You may also like
Source: SEC filing on October 26, 2023.